Study #2016-1134
Repetitive transcranial magnetic stimulation (rTMS) to treat oxaliplatin-induced neuropathy
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This trial studies how well repetitive transcranial magnetic stimulation (rTMS) works in improving neuropathy due to oxaliplatin chemotherapy in patients with stage I-IV cancer. rTMS is designed to change brain activity by introducing small magnetic impulses to the scalp that encourage the brain to change its activity.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Malignant Neoplasm;Neuropathy
Study phase:
Not applicable
Physician name:
Sarah Prinsloo
Department:
Integrative Medicine Program
For general questions about clinical trials:
1-855-581-8877
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.